Showing results (21-30 of 111) with videos related to

Sort By:
Pageof 12
Journal of Medical Economics|April 27, 2026
Cost-effectiveness analysis of lorlatinib as first-line treatment for anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer in ItalyIlaria Valentini, Filippo Rumi, Eugenio Di Brino, et al.
Frontiers in Oncology|February 29, 2024
Case report: First evidence of impressive efficacy of modulated dose selpercatinib in a young Caucasian with ANK3-RET fusion-positive NSCLCElisa De Carlo, Elisa Bertoli, Monica Schiappacassi, et al.
International Journal of Molecular Sciences|December 17, 2024
Navigating Therapeutic Challenges in BRAF-Mutated NSCLC: Non-V600 Mutations, Immunotherapy, and Overcoming ResistanceMartina Bortolot, Sara Torresan, Elisa De Carlo, et al.
International Journal of Molecular Sciences|June 24, 2022
Brain Metastases Management in Oncogene-Addicted Non-Small Cell Lung Cancer in the Targeted Therapies EraElisa De Carlo, Elisa Bertoli, Alessandro Del Conte, et al.
International Journal of Molecular Sciences|June 24, 2022
Bone Metastasis and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC): Microenvironment and Possible Clinical ImplicationsAlessandro Del Conte, Elisa De Carlo, Elisa Bertoli, et al.
International Journal of Molecular Sciences|July 9, 2022
Acquired Resistance to Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer: How Do We Overcome It?Elisa Bertoli, Elisa De Carlo, Alessandro Del Conte, et al.
Cancers|May 14, 2025
Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor (EGFR) Common Mutations: New StrategiesBrigida Stanzione, Alessandro Del Conte, Elisa Bertoli, et al.
The Cochrane Database of Systematic Reviews|January 22, 2010
Interferon-alpha for maintenance of follicular lymphomaPaolo Baldo, Maurizio Rupolo, Anna Compagnoni, et al.
Pageof 12